Furthermore, we suggested that Selinexor (KTP-330), a clinically available inhibitor of exportin 1 (XPO1) protein, could suppress the growth of NB by inducing nuclear accumulation of E2F7, and combine with GSK-J4 to enhance NB regression. Here, E2F7 is linked to neuroblastoma.